ICAM1 and neoplasm: Other authors found that PC and non-cancer cases could be differentiated using serum concentrations of intercellular adhesion molecule 1 (ICAM1), reporting higher sensitivity and specificity for this biomarker than for CA19-9, although it was not possible to discriminate between early and late tumor stages [23].